In today's medical environment, personalised medicine is a significant movement. It tries to shift the focus away from the old practise of prescribing standard doses of standard medications to every patient for a condition and toward targeting the specific drug and dose required based on the patient's physiology. Nanotechnology and personalised medicine are two of the newest areas of biomedical research, as well as two of the most promising technologies for enhancing health care and outcomes. In addition, they are fast convergent in a variety of current and future therapeutic applications. Nanotechnology has a number of benefits for personalised medicine applications, including a size that matches the scale of personalised medicine's molecular substrates, increased sensitivity in detecting and binding with target molecules, and flexibility in the design and features of diagnostics and therapeutics at the nano scale.
Title : Pharmacogenomics: current status and future directions
Matthias Schwab, University of Tübingen, Germany
Title : Monitoring Folds Localization in ultra-thin Transition Metal Dichalcogenides using Optical Harmonic Generation
Ahmed Raza Khan, Australian National University, Australia
Title : Will be updated soon.
Alireza Haghighi, Harvard International Center for Genetic Disease, United States